The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate

Little data exist on the effects of adjunctive therapy with leuprolide acetate (LA) in the luteal phase of women with polycystic ovary syndrome (PCOS) undergoing ovulation induction with human menopausal gonadotropin (hMG). Additionally, it is not known whether gonadal steroid concentrations in the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fertility and sterility 1990-07, Vol.54 (1), p.27-31
Hauptverfasser:	Bachus, Kevin E., Hughes, Claude L., Haney, A.F., Dodson, William C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Drug Therapy, Combination Estradiol - blood Female Genital system. Reproduction Gonadotropin-Releasing Hormone - administration & dosage Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - therapeutic use Humans Infertility, Female - drug therapy Infertility, Female - etiology Leuprolide Luteal Phase Medical sciences Menotropins - administration & dosage Menotropins - therapeutic use Ovulation Induction Pharmacology. Drug treatments Polycystic Ovary Syndrome - blood Polycystic Ovary Syndrome - complications Polycystic Ovary Syndrome - drug therapy Pregnancy Progesterone - blood Prospective Studies Random Allocation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!